Immunic
IMUX
$1.25
Share price
1.83%
Change (1 day)
-30.98%
Change (1 year)
Categories
Immunic (IMUX) - Cash on Hand
Cash on Hand as of December 2024 : C$49.35 Million
According to Immunic's latest financial reports the company has C$49.35 Million in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Immunic - Cash on Hand chart (from 2012 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | C$61.9 M | -60.8% |
| 2022-12-31 | C$0.15 B | 42.65% |
| 2021-12-31 | C$0.11 B | -31.88% |
| 2020-12-31 | C$0.16 B | 323.67% |
| 2019-12-31 | C$38.35 M | 111.34% |
| 2018-12-31 | C$18.14 M | -74.63% |
| 2017-12-31 | C$71.53 M | -11.26% |
| 2016-12-31 | C$80.61 M | -30.33% |
| 2015-12-31 | C$0.11 B | -2.47% |
| 2014-12-31 | C$0.11 B | 191.88% |
| 2013-12-31 | C$40.64 M | 121.28% |
| 2012-12-31 | C$18.36 M | 2148.93% |
| 2011-12-31 | C$0.81 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | C$0.35 B | 617.62% | 🇺🇸 USA |